Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer
2018-11-26 21:30
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method
2018-11-26 21:00
CStone initiates a bridging Phase I clinical trial for PD-1 antibody CS1003 with first patient dosed in China
2018-11-19 12:54
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis
2018-11-19 07:00
MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210
2018-11-16 05:01
Foresee Pharmaceuticals Announces Sr. VP of Pharmaceutics and Manufacturing Appointment
2018-11-15 20:33
TWi Biotechnology, Inc. Announces Last Patient Enrolled in Phase 2 Study of AC-201CR for Treatment of Hemophilic Arthropathy
2018-11-15 17:16
China Jo-Jo Drugstores Reports Second Quarter 2019 Financial Results
2018-11-14 21:30
Sanofi holds China Health Road Symposium at CIIE
2018-11-14 11:20
Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Six Months Ended September 30, 2018
2018-11-13 20:00
Metrics Contract Services Announces Serialization Capabilities at Greenville Site
2018-11-13 04:29
The First Pellino-1 Inhibitor BBT-401 Confirms Its Safety and Tolerability from the Phase I Study
2018-11-12 16:00
GCAM Adds New Plasma Collection Centers
2018-11-09 16:16
Marken Assists In Fight Against Polio
2018-11-06 19:00
Curevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate
2018-11-05 23:00
China Biologic Reports Financial Results for the Third Quarter of 2018
2018-11-02 04:30
Metrics Contract Services Adds Commercial Gerteis Roller Compaction Capabilities
2018-11-01 20:00
Strategic Cooperation between GeneQuantum Healthcare and Biocytogen on Development of Antitumor Bioconjugates
2018-11-01 10:00
Adagene Announces First Patient Dosed in United States and Acceptance of IND in China for ADG-106
2018-11-01 08:00
WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang
2018-10-31 16:08
1
135
136
137
138
139
165